Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (321-330 of 6,822) with videos related to

Pageof 683
Sort By:
Nature Biotechnology|September 10, 2014
RAC to finally relax gene therapy oversightAsher Mullard
Nature Reviews. Drug Discovery|May 1, 2026
First-in-class HIV drug nabs approvalAsher Mullard
Nature Reviews. Drug Discovery|April 2, 2026
FDA approves GLP-1 pill for obesityAsher Mullard
Nature Reviews. Drug Discovery|December 30, 2016
Cures Act shakes up the FDA and NIHAsher Mullard
Nature|December 1, 2016
Stem cells: Stemming the tideAsher Mullard
Nature Reviews. Drug Discovery|December 30, 2016
R&D returns continue to fallAsher Mullard
Lancet (London, England)|March 12, 2014
FDA's rejection of alemtuzumab divides neurologistsAsher Mullard
The Lancet. Diabetes & Endocrinology|March 14, 2014
Outcome results renew debate about diabetes drug developmentAsher Mullard
Memory & Cognition|April 23, 2008
Easy comes, easy goes? The link between learning and remembering and its exploitation in metacognitionAsher Koriat
Nature Reviews. Drug Discovery|June 13, 2025
Keeping the immuno-oncology flame burningAsher Mullard
Pageof 683

Showing results (321-330 of 6,822) with videos related to

Sort By:
Pageof 683
Nature Biotechnology|September 10, 2014
RAC to finally relax gene therapy oversightAsher Mullard
Nature Reviews. Drug Discovery|May 1, 2026
First-in-class HIV drug nabs approvalAsher Mullard
Nature Reviews. Drug Discovery|April 2, 2026
FDA approves GLP-1 pill for obesityAsher Mullard
Nature Reviews. Drug Discovery|December 30, 2016
Cures Act shakes up the FDA and NIHAsher Mullard
Nature|December 1, 2016
Stem cells: Stemming the tideAsher Mullard
Nature Reviews. Drug Discovery|December 30, 2016
R&D returns continue to fallAsher Mullard
Lancet (London, England)|March 12, 2014
FDA's rejection of alemtuzumab divides neurologistsAsher Mullard
The Lancet. Diabetes & Endocrinology|March 14, 2014
Outcome results renew debate about diabetes drug developmentAsher Mullard
Memory & Cognition|April 23, 2008
Easy comes, easy goes? The link between learning and remembering and its exploitation in metacognitionAsher Koriat
Nature Reviews. Drug Discovery|June 13, 2025
Keeping the immuno-oncology flame burningAsher Mullard
Pageof 683